A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old
Clinical trial NCT05375838 · COMPLETED
Trial details
- NCT number
- NCT05375838
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2022-12-29
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.